These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 16918820)
1. Very low level of microalbuminuria is associated with increased risk of death in subjects with cardiovascular or cerebrovascular diseases. Klausen KP; Scharling H; Jensen JS J Intern Med; 2006 Sep; 260(3):231-7. PubMed ID: 16918820 [TBL] [Abstract][Full Text] [Related]
2. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Klausen K; Borch-Johnsen K; Feldt-Rasmussen B; Jensen G; Clausen P; Scharling H; Appleyard M; Jensen JS Circulation; 2004 Jul; 110(1):32-5. PubMed ID: 15210602 [TBL] [Abstract][Full Text] [Related]
3. The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality. Klausen KP; Parving HH; Scharling H; Jensen JS J Intern Med; 2007 Oct; 262(4):470-8. PubMed ID: 17875184 [TBL] [Abstract][Full Text] [Related]
4. Microalbuminaria and the risk of atherosclerosis. Clinical epidemiological and physiological investigations. Jensen JS Dan Med Bull; 2000 Apr; 47(2):63-78. PubMed ID: 10822799 [TBL] [Abstract][Full Text] [Related]
5. [Microalbuminuria is associated with a fourfold increased risk of ischemic heart disease among hypertensive patients]. Jensen JS; Feldt-Rasmussen BF; Strandgaard S; Schroll M; Borch-Johnsen K Ugeskr Laeger; 2002 Aug; 164(32):3773-7. PubMed ID: 12362612 [TBL] [Abstract][Full Text] [Related]
7. New definition of microalbuminuria in hypertensive subjects: association with incident coronary heart disease and death. Klausen KP; Scharling H; Jensen G; Jensen JS Hypertension; 2005 Jul; 46(1):33-7. PubMed ID: 15928029 [TBL] [Abstract][Full Text] [Related]
8. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Arnlöv J; Evans JC; Meigs JB; Wang TJ; Fox CS; Levy D; Benjamin EJ; D'Agostino RB; Vasan RS Circulation; 2005 Aug; 112(7):969-75. PubMed ID: 16087792 [TBL] [Abstract][Full Text] [Related]
9. Definition of kidney dysfunction as a cardiovascular risk factor: use of urinary albumin excretion and estimated glomerular filtration rate. Cirillo M; Lanti MP; Menotti A; Laurenzi M; Mancini M; Zanchetti A; De Santo NG Arch Intern Med; 2008 Mar; 168(6):617-24. PubMed ID: 18362254 [TBL] [Abstract][Full Text] [Related]
10. The importance of microalbuminuria as a cardiovascular risk indicator: A review. Diercks GF; van Boven AJ; Hillege JL; de Jong PE; Rouleau JL; van Gilst WH Can J Cardiol; 2002 May; 18(5):525-35. PubMed ID: 12032579 [TBL] [Abstract][Full Text] [Related]
11. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study. Hallan S; Astor B; Romundstad S; Aasarød K; Kvenild K; Coresh J Arch Intern Med; 2007 Dec; 167(22):2490-6. PubMed ID: 18071172 [TBL] [Abstract][Full Text] [Related]
12. Microalbuminuria in treated hypertensives: only a mirror image of cardiovascular risk? The HUNT Study, Norway. Kvenild K; Romundstad S; Midthjell K; Krüger O; Hallan H; Holmen J Scand J Prim Health Care; 2006 Sep; 24(3):145-53. PubMed ID: 16923623 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex. Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR J Hypertens; 2008 Jan; 26(1):26-34. PubMed ID: 18090537 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of increased albumin excretion rate in young saudi adults. Abo-Zenah H; El-Benayan A; El Nahas AM Nephron Clin Pract; 2008; 108(2):c155-62. PubMed ID: 18259102 [TBL] [Abstract][Full Text] [Related]
15. Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. Lambers Heerspink HJ; Brantsma AH; de Zeeuw D; Bakker SJ; de Jong PE; Gansevoort RT; Am J Epidemiol; 2008 Oct; 168(8):897-905. PubMed ID: 18775924 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion. Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT; Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082 [TBL] [Abstract][Full Text] [Related]
17. Urinary albumin and cardiovascular profile in the middle-aged population. Cirillo M; Lombardi C; Bilancio G; Chiricone D; Stellato D; De Santo NG Semin Nephrol; 2005 Nov; 25(6):367-71. PubMed ID: 16298257 [TBL] [Abstract][Full Text] [Related]
18. Risk factors for development of microalbuminuria in diabetic and nondiabetic normoalbuminuric hypertensives with high or very high cardiovascular risk - a twelve-month follow-up study. Cotter J; Oliveira P; Cunha P; Polónia J Nephron Clin Pract; 2009; 113(1):c8-15. PubMed ID: 19590230 [TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor: the link between cardiovascular risk factors and microalbuminuria? Asselbergs FW; de Boer RA; Diercks GF; Langeveld B; Tio RA; de Jong PE; van Veldhuisen DJ; van Gilst WH Int J Cardiol; 2004 Feb; 93(2-3):211-5. PubMed ID: 14975549 [TBL] [Abstract][Full Text] [Related]
20. Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) study. Diercks GF; van Boven AJ; Hillege HL; Janssen WM; Kors JA; de Jong PE; Grobbee DE; Crijns HJ; van Gilst WH Eur Heart J; 2000 Dec; 21(23):1922-7. PubMed ID: 11071797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]